Funds holding CONTRA LIGAND PHARMACE- NPV
2 funds declare a position · 0 ETFs and 2 other funds · 0 $ · US532CNT0118
Each line carries its report date.
| Fund | Shares | Value | Weight | |
|---|---|---|---|---|
| S&P SmallCap 600 Pure Growth Fund Rydex Variable Trust | 169 | 0 $ | as of Mar 31, 2026 · Original filing | |
| S&P SmallCap 600 Pure Growth Fund Rydex Series Funds | 107 | 0 $ | as of Mar 31, 2026 · Original filing |